10 Einträge gefunden

1. Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers

   1. Khan, Sabrina S
   2. Karn, Thomas
   3. Symmans, W Fraser
   4. Rody, Achim
   5. Müller, Volkmar
   6. Holtrich, Uwe
   7. Becker, Sven

   2015 - Forschungsinformationssystem des UKE
2. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Schmidt, Marcus
   4. Karn, Thomas
   5. Becker, Sven
   6. Wirtz, Ralph
   7. Rody, Achim

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
3. Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

   1. Karn, Thomas
   2. Rody, Achim
   3. Müller, Volkmar
   4. Schmidt, Marcus
   5. Becker, Sven
   6. Holtrich, Uwe
   7. Pusztai, Lajos

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
4. OPG and PgR show similar cohort-specific effects as prognostic factors in ER positive breast cancer

   1. Sänger, Nicole
   2. Ruckhäberle, Eugen
   3. Bianchini, Giampaolo
   4. Heinrich, Tomas
   5. Milde-Langosch, Karin
   6. Müller, Volkmar
   7. Rody, Achim

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
5. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

   1. Harbeck, Nadia
   2. Beckmann, Matthias W
   3. Rody, Achim
   4. Schneeweiss, Andreas
   5. Müller, Volkmar
   6. Fehm, Tanja
   7. Marschner, Norbert

   2013 - Forschungsinformationssystem des UKE
6. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

   1. Schütze, Dina
   2. Milde-Langosch, Karin
   3. Witzel, Isabell
   4. Rody, Achim
   5. Karn, Thomas
   6. Schmidt, Marcus
   7. Choschzick, Matthias

   2013 - Forschungsinformationssystem des UKE
7. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

   1. Milde-Langosch, Karin
   2. Karn, Thomas
   3. Müller, Volkmar
   4. Witzel, Isabell
   5. Rody, Achim
   6. Schmidt, Markus
   7. Wirtz, Ralph M

   2013 - Forschungsinformationssystem des UKE
8. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

   1. Karn, Thomas
   2. Ruckhäberle, Eugen
   3. Hanker, Lars
   4. Müller, Volkmar
   5. Schmidt, Marcus
   6. Solbach, Christine
   7. Gätje, Regine

   2011 - Forschungsinformationssystem des UKE
9. A clinically relevant gene signature in triple negative and basal-like breast cancer.

   1. Rody, Achim
   2. Karn, Thomas
   3. Liedtke, Cornelia
   4. Pusztai, Lajos
   5. Ruckhaeberle, Eugen
   6. Hanker, Lars
   7. Gaetje, Regine

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
10. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.

    1. Rody, Achim
    2. Karn, Thomas
    3. Ruckhäberle, Eugen
    4. Hanker, Lars
    5. Metzler, Dirk
    6. Müller, Volkmar
    7. Solbach, Christine

    2009 - Forschungsinformationssystem des UKE